DNTH logo

Dianthus Therapeutics (DNTH) Financials

Balance sheets

Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 1, 2023Dec 31, 2022Sep 30, 2022

Total Assets

$354.2 M(-4.0%)$369.0 M(-3.5%)$382.5 M(+113.2%)$179.4 M(-6.8%)$192.5 M--$83.1 M-

Current Assets

$287.5 M(-21.4%)$365.7 M(-4.0%)$380.9 M(+114.7%)$177.5 M(-7.3%)$191.5 M--$82.0 M-

Non Current Assets

$66.8 M(+1940.3%)$3.3 M(+113.0%)$1.5 M(-21.4%)$2.0 M(+93.7%)$1.0 M--$1.1 M-

Total Liabilities

$16.4 M(+52.2%)$10.7 M(+9.9%)$9.8 M(-7.2%)$10.5 M(-25.2%)$14.1 M--$9.5 M-

Current Liabilities

$15.7 M(+56.6%)$10.0 M(+11.9%)$9.0 M(-7.0%)$9.6 M(-26.4%)$13.1 M--$8.2 M-

Long Term Liabilities

$640.0 K(-10.1%)$712.0 K(-12.8%)$816.0 K(-9.7%)$904.0 K(-9.8%)$1.0 M--$1.2 M-

Shareholders Equity

$337.9 M(-5.7%)$358.2 M(-3.9%)$372.7 M(+120.7%)$168.9 M(-5.3%)$178.4 M--$73.7 M-

Book Value

$337.9 M(-5.7%)$358.2 M(-3.9%)$372.7 M(+120.7%)$168.9 M(-5.3%)$178.4 M---$44.4 M-

Working Capital

$271.8 M(-23.6%)$355.7 M(-4.4%)$372.0 M(+121.7%)$167.8 M(-5.9%)$178.4 M--$73.8 M-

Cash And Cash Equivalents

$33.7 M(-89.3%)$314.2 M(-4.7%)$329.7 M(+149.2%)$132.3 M(-15.9%)$157.3 M--$15.4 M-

Accounts Payable

$7.6 M(+104.9%)$3.7 M(+41.5%)$2.6 M(+0.1%)$2.6 M(+90.7%)$1.4 M--$1.2 M-

Accounts Receivable

---------

Short Term Debt

$311.0 K(-17.5%)$377.0 K(-5.8%)$400.0 K(-4.1%)$417.0 K(+1.0%)$413.0 K--$350.0 K-

Long Term Debt

$0.0(-100.0%)$30.0 K(-69.1%)$97.0 K(-42.3%)$168.0 K(-34.6%)$257.0 K--$438.0 K-

Total Debt

$311.0 K(-23.6%)$407.0 K(-18.1%)$497.0 K(-15.0%)$585.0 K(-12.7%)$670.0 K(+100.0%)$0.0(0%)$0.0(-100.0%)$788.0 K(+100.0%)$0.0

Debt To Equity

0.0(0%)0.0(0%)0.0(0%)0.0(0%)0.0--0.0-

Current Ratio

18.3(-49.8%)36.5(-14.3%)42.5(+130.7%)18.4(+25.9%)14.6--10.0-

Quick Ratio

---------

Inventory

---------

Retained Earnings

-$146.0 M(-20.8%)-$120.8 M(-17.1%)-$103.2 M(-15.4%)-$89.4 M(-13.4%)-$78.9 M---$45.9 M-

PB Ratio

2.4(+12.3%)2.1(-10.2%)2.4(+159.3%)0.9(-20.2%)1.1----

Income statements

Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 1, 2023Dec 31, 2022Sep 30, 2022

EPS

-$0.7(-45.1%)-$0.5(+5.6%)-$0.5(+24.3%)-$0.7(+81.1%)-$3.8(-402.8%)-$0.8(-57.1%)-$0.5(+29.9%)-$0.7(-30.0%)-$0.5

TTM EPS

-$2.5(+54.8%)-$5.5(+4.2%)-$5.8(-1.1%)-$5.7(-0.5%)-$5.7(-133.5%)-$2.4(-44.6%)-$1.7(-39.6%)-$1.2(-130.0%)-$0.5

Revenue

$2.2 M(+16.6%)$1.9 M(+113.2%)$874.0 K(+91.3%)$457.0 K(-50.5%)$924.0 K(-4.6%)$969.0 K(+103.6%)$476.0 K(-59.5%)$1.2 M(+0.2%)$1.2 M

TTM Revenue

$5.4 M(+30.3%)$4.1 M(+27.7%)$3.2 M(+14.1%)$2.8 M(-20.3%)$3.5 M(-6.6%)$3.8 M(+34.3%)$2.8 M(+20.3%)$2.3 M(+100.2%)$1.2 M

Total Expenses

$32.1 M(+33.3%)$24.1 M(+28.6%)$18.7 M(+39.5%)$13.4 M(-19.6%)$16.7 M(+30.9%)$12.7 M(+56.2%)$8.2 M(-31.3%)$11.9 M(+25.9%)$9.4 M

Operating Expenses

$32.1 M(+33.3%)$24.1 M(+28.6%)$18.7 M(+39.5%)$13.4 M(-19.6%)$16.7 M(+30.9%)$12.7 M(+56.2%)$8.2 M(-31.3%)$11.9 M(+25.9%)$9.4 M

Cost Of Goods Sold

---------

TTM Cost Of Goods Sold

---------

Gross Profit

---------

TTM Gross Profit

---------

Gross Margin

---------

Operating Profit

-$29.9 M(-34.7%)-$22.2 M(-24.4%)-$17.8 M(-37.7%)-$13.0 M(+17.8%)-$15.8 M(-33.8%)-$11.8 M(-53.3%)-$7.7 M(+28.1%)-$10.7 M(-29.6%)-$8.3 M

TTM Operating Profit

-$82.9 M(-20.6%)-$68.8 M(-17.9%)-$58.3 M(-21.1%)-$48.2 M(-4.9%)-$45.9 M(-19.5%)-$38.4 M(-44.2%)-$26.6 M(-40.5%)-$18.9 M(-129.6%)-$8.3 M

Operating Margin

-1376.6%(-15.5%)-1191.8%(+41.6%)-2041.7%(+28.0%)-2835.0%(-66.2%)-1705.5%(-40.3%)-1215.3%(+24.7%)-1614.1%(-77.4%)-910.0%(-29.3%)-703.7%

Net Income

-$25.2 M(-43.0%)-$17.6 M(-28.1%)-$13.7 M(-30.1%)-$10.6 M(+28.4%)-$14.8 M(-32.5%)-$11.1 M(-57.1%)-$7.1 M(+29.9%)-$10.1 M(-30.0%)-$7.8 M

TTM Net Income

-$67.1 M(-18.4%)-$56.7 M(-12.9%)-$50.2 M(-15.3%)-$43.6 M(-1.0%)-$43.1 M(-19.3%)-$36.1 M(-44.6%)-$25.0 M(-39.6%)-$17.9 M(-130.0%)-$7.8 M

Net Margin

-1159.0%(-22.6%)-945.1%(+39.9%)-1573.0%(+31.9%)-2311.4%(-44.7%)-1597.7%(-39.0%)-1149.6%(+22.8%)-1489.3%(-73.0%)-860.9%(-29.7%)-663.6%

EBIT

-$29.9 M(-34.7%)-$22.2 M(-24.4%)-$17.8 M(-37.7%)-$13.0 M(+17.8%)-$15.8 M(-33.8%)-$11.8 M(-53.3%)-$7.7 M(+28.1%)-$10.7 M(-29.6%)-$8.3 M

TTM EBIT

-$82.9 M(-20.6%)-$68.8 M(-17.9%)-$58.3 M(-21.1%)-$48.2 M(-4.9%)-$45.9 M(-19.5%)-$38.4 M(-44.2%)-$26.6 M(-40.5%)-$18.9 M(-129.6%)-$8.3 M

EBITDA

-$29.8 M(-34.8%)-$22.1 M(-24.6%)-$17.7 M(-38.0%)-$12.9 M(+18.0%)-$15.7 M(-34.0%)-$11.7 M(-53.8%)-$7.6 M(+28.6%)-$10.6 M(-29.0%)-$8.3 M

TTM EBITDA

-$82.5 M(-20.6%)-$68.4 M(-17.9%)-$58.0 M(-21.2%)-$47.8 M(-4.8%)-$45.6 M(-19.4%)-$38.2 M(-44.1%)-$26.5 M(-40.2%)-$18.9 M(-129.0%)-$8.3 M

Selling, General & Administrative Expenses

$6.5 M(+8.8%)$6.0 M(+6.3%)$5.6 M(+21.8%)$4.6 M(-46.9%)$8.7 M(+250.0%)$2.5 M(+7.8%)$2.3 M(+13.5%)$2.0 M(-7.8%)$2.2 M

TTM SGA

$22.8 M(-8.8%)$25.0 M(+16.3%)$21.5 M(+18.3%)$18.2 M(+16.7%)$15.6 M(+72.0%)$9.1 M(+38.0%)$6.6 M(+54.5%)$4.2 M(+92.2%)$2.2 M

Depreciation And Amortization

$116.0 K(+4.5%)$111.0 K(+3.7%)$107.0 K(+3.9%)$103.0 K(+18.4%)$87.0 K(+3.6%)$84.0 K(+3.7%)$81.0 K-$98.0 K

TTM D&A

$437.0 K(+7.1%)$408.0 K(+7.1%)$381.0 K(+7.3%)$355.0 K(+40.9%)$252.0 K(-4.2%)$263.0 K(+46.9%)$179.0 K-$98.0 K

Interest Expense

---------

TTM Interest Expense

---------

Income Tax

---------

TTM Income Tax

---------

PE Ratio

---------

PS Ratio

149.8(-18.8%)184.5(-32.5%)273.1(+400.8%)54.5(-4.6%)57.2----

Cashflow statements

Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 1, 2023Dec 31, 2022Sep 30, 2022

Cash From Operations

-$21.3 M(-46.4%)-$14.5 M(+2.8%)-$14.9 M(-26.0%)-$11.9 M(-18.6%)-$10.0 M(-111.2%)-$4.7 M(+54.0%)-$10.3 M--$20.2 M

TTM CFO

-$62.6 M(-22.0%)-$51.3 M(-23.6%)-$41.5 M(-12.6%)-$36.9 M(-47.4%)-$25.0 M(+29.0%)-$35.2 M(-15.5%)-$30.5 M--$20.2 M

Cash From Investing

-$259.4 M(-22286.8%)$1.2 M(+121.2%)-$5.5 M(+33.1%)-$8.2 M(+28.4%)-$11.5 M(-152.6%)$21.9 M(+20.6%)$18.1 M--$47.2 M

TTM CFI

-$271.9 M(-1029.3%)-$24.1 M(-611.4%)-$3.4 M(-116.7%)$20.3 M(-28.9%)$28.5 M(+498.0%)-$7.2 M(+75.3%)-$29.0 M--$47.2 M

Cash From Financing

$296.0 K(+113.5%)-$2.2 M(-101.0%)$217.8 M(+4577.8%)-$4.9 M(-103.5%)$138.4 M(+100.0%)$0.0(0%)$0.0-$96.7 M

TTM CFF

$211.1 M(-39.6%)$349.2 M(-0.6%)$351.4 M(+163.1%)$133.6 M(-3.5%)$138.4 M(+43.2%)$96.7 M(0%)$96.7 M-$96.7 M

Free Cash Flow

-$21.3 M(-46.4%)-$14.5 M(+2.9%)-$15.0 M(-26.2%)-$11.9 M(-18.0%)-$10.1 M(-111.6%)-$4.8 M(+53.9%)-$10.3 M--$20.3 M

TTM FCF

-$62.7 M(-21.8%)-$51.4 M(-23.5%)-$41.6 M(-12.7%)-$37.0 M(-47.3%)-$25.1 M(+29.0%)-$35.4 M(-15.5%)-$30.6 M--$20.3 M

CAPEX

$25.0 K(+47.1%)$17.0 K(-46.9%)$32.0 K(+220.0%)$10.0 K(-84.6%)$65.0 K(+209.5%)$21.0 K(+50.0%)$14.0 K-$110.0 K

TTM CAPEX

$84.0 K(-32.3%)$124.0 K(-3.1%)$128.0 K(+16.4%)$110.0 K(+10.0%)$100.0 K(-31.0%)$145.0 K(+16.9%)$124.0 K-$110.0 K

Dividends Paid

---------

TTM Dividends Paid

---------

TTM Dividend Per Share

---------

TTM Dividend Yield

---------

Payout Ratio

---------